Primary Cryopreserved Human Hepatocytes and Media
Closed Solicitation Posted
- Solicitation number
- 75F40124Q-123069
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Jefferson, Arkansas 72079, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Food and Drug Administration (FDA), National Center of Toxicological Research (NCTR), Division of Biochemical Toxicology (DBT) is seeking to acquire 110 vials of primary cryopreserved human hepatocytes from single and multiple donors, with each vial containing at least 5 million viable cells. The hepatocytes will be used for studying the toxicity of several drugs and identifying the responsible metabolic enzymes. The solicitation is set as a Firm-Fixed Price purchase order, and the Government will award to the lowest priced technically acceptable offeror. Quotes are due by May 27, 2024 at 12:00 pm CT.
This opportunity is set aside for total small business. The place of performance is Jefferson, AR 72079, USA. The Government has not provided any information about potential incumbents or current contractors. Payment terms are net 30 days after Government acceptance.
Notice text
Primary Cryopreserved Human Hepatocytes and Media per the attached Combined Synopsis Solicitation 75F40124Q-123069.
Files
| File | Type | Posted |
|---|---|---|
| 75F40124Q-123069.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity